Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Hoffmann-La Roche
Hoffmann-La Roche
Alliance Foundation Trials, LLC.
Washington University School of Medicine
Palleos Healthcare GmbH
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Wake Forest University Health Sciences
NRG Oncology
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of California, San Francisco
UNC Lineberger Comprehensive Cancer Center
University of Cincinnati
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche
Apexigen America, Inc.
The University of Texas Health Science Center at San Antonio
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Loma Linda University
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoffmann-La Roche
Barbara Ann Karmanos Cancer Institute
Genentech, Inc.
Alliance for Clinical Trials in Oncology
Hoffmann-La Roche
CEL-SCI Corporation
Radiation Therapy Oncology Group
Alliance for Clinical Trials in Oncology
Northwestern University
SCRI Development Innovations, LLC